Common Stock, Shares, Issued of Vitro Biopharma, Inc. from 31 Oct 2010 to 31 Oct 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Vitro Biopharma, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Oct 2010 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending 31 Oct 2025 was 4,460,535, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 4,460,535 0 0% 31 Oct 2025 10-K 13 Feb 2026 2025 FY
Q2 2025 4,460,535 0 0% 31 Jul 2025 10-Q 12 Sep 2025 2025 Q3
Q1 2025 4,460,535 0 0% 30 Apr 2025 10-Q 20 Jun 2025 2025 Q2
Q4 2024 4,460,535 0 0% 31 Jan 2025 10-Q 20 Mar 2025 2025 Q1
Q3 2024 4,460,535 0 0% 31 Oct 2024 10-K 13 Feb 2026 2025 FY
Q2 2024 4,460,535 +29,990 +0.68% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 4,460,535 -110,699,645 -96% 30 Apr 2024 10-Q 31 May 2024 2024 Q2
Q4 2023 4,460,535 -110,699,645 -96% 31 Jan 2024 10-Q 14 Mar 2024 2024 Q1
Q3 2023 4,460,535 +30,000 +0.68% 31 Oct 2023 10-Q 20 Mar 2025 2025 Q1
Q2 2023 4,430,545 31 Jul 2023 10-Q 28 Aug 2023 2023 Q3
Q1 2023 115,160,180 30 Apr 2023 10-Q 13 Jun 2023 2023 Q2
Q4 2022 115,160,180 31 Jan 2023 10-Q 14 Mar 2023 2023 Q1
Q3 2022 4,430,535 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q3 2015 20,371,822 +400,000 +2% 31 Oct 2015 10-K 22 Sep 2016 2015 FY
Q2 2015 19,971,822 +53,476 +0.27% 31 Jul 2015 10-Q 30 Mar 2016 2015 Q3
Q1 2015 19,971,822 30 Apr 2015 10-Q 22 Jan 2016 2015 Q2
Q4 2014 19,971,822 31 Jan 2015 10-Q 24 Mar 2015 2015 Q1
Q3 2014 19,971,822 +168,419 +0.85% 31 Oct 2014 10-K 22 Sep 2016 2015 FY
Q2 2014 19,918,346 +114,943 +0.58% 31 Jul 2014 10-Q 22 Sep 2014 2014 Q3
Q3 2013 19,803,403 +494,491 +2.6% 31 Oct 2013 10-K 13 Feb 2015 2014 FY
Q2 2013 19,803,403 +494,491 +2.6% 31 Jul 2013 10-Q 23 Sep 2013 2013 Q3
Q1 2013 19,553,403 +682,186 +3.6% 30 Apr 2013 10-Q 18 Jun 2013 2013 Q2
Q4 2012 19,308,912 +437,695 +2.3% 31 Jan 2013 10-Q 21 Mar 2013 2013 Q1
Q3 2012 19,308,912 +779,917 +4.2% 31 Oct 2012 10-K 12 Feb 2014 2013 FY
Q2 2012 19,308,912 +829,917 +4.5% 31 Jul 2012 10-Q/A 17 Oct 2012 2012 Q3
Q1 2012 18,871,217 +18,772,207 +18960% 30 Apr 2012 10-Q/A 22 Jun 2012 2012 Q2
Q4 2011 18,871,217 31 Jan 2012 10-Q 21 Mar 2012 2012 Q1
Q3 2011 18,528,995 +149,010 +0.81% 31 Oct 2011 10-K 12 Feb 2013 2012 FY
Q2 2011 18,478,995 31 Jul 2011 10-Q/A 12 Oct 2011 2011 Q3
Q1 2011 99,010 27 Apr 2011 10-K 12 Feb 2013 2012 FY
Q3 2010 18,379,985 31 Oct 2010 10-K/A 16 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.